openPR Logo
Press release

Digital Genome Market | Pinnacle Companies :- Life Technologies, Illumina, Thermo Fisher Scientific, Roche, Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: proton/ PGM sequencing and SOLiD (sequencing by Oligonucleotide Ligation and Detec

08-30-2018 09:54 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Digital Genome Market | Pinnacle Companies :- Life

Digital Genome Market size is set to exceed USD 45 billion by 2024; as per a new research report by Global Market Insights, Inc.

Increased adoption of personalized medicine aimed at identifying genomic markers of disease and prescribe drugs that specifically target the pathway will drive the digital genome market size. Growing emphasis on sensitivity and specificity of the gene sequencing instruments should also fuel industry growth.

In 2015, sequencing and analyzing instruments accounted for over 40% of digital genome market share. Technological innovation for development of novel instruments coupled with growing investments in genetic research will provide thrust to industry expansion. Sequencing chips should witness over 10% CAGR owing to continuous R&D in bioinformatics, microfluidics, enzymology, and nanotechnology providing innovative platforms for digital genome market growth.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1219

Biotechnology innovation has enabled development of genetically modified organisms (GMOs) in order to introduce specific improvements or traits. Successful production and commercialization of such modified organisms should stimulate business growth. Extensive applications in clinical diagnosis and research will also contribute to industry growth.

Effective disease management strategies for chronic ailments and growing number of private and public investments and grants are forecast to propel digital genome market growth over the forecast years.

Concerns pertaining to security and confidentiality of patient data, lack of experienced professional and complex return on investment structure may hamper the digital genome market growth. Increasing application of digital genomics in next generation sequencing and wide use of microbes in diagnostics industry will stimulate microbiology segment growth; the segment is anticipated to surpass USD 10 billion by 2024.

Bio-pharmaceutical companies accounted for over 45% of digital genome market share due to increasing demand for targeted drug therapy. Growing usage trend for precision medicines should provide lucrative growth opportunities for segment growth.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1219

U.S. digital genome market size accounted for over 80% of the North American revenue in 2015, mainly due to the presence of established healthcare infrastructure and advanced facilities for effective treatment and care. The successful completion of Human Genome Project (HGP) has attracted significant public and private initiatives, driving the business growth.

In 2015, Germany digital genome market size was valued at over USD 1.4 billion and is anticipated to witness considerable growth till 2024. Increasing investments by public and private companies for development of novel technologies should boost digital genome industry growth.

China digital genome market is set to witness over 10% CAGR owing to favorable government initiative for development of human genetic resources platform and increasing collaboration among research institutes for creation of genomic databases and biobanks.

Some of the players operating in this industry include Perkin Elmer, Qiagen, Illumina, Becton Dickinson, Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, Veracyte, Trovagene, Affymetrix and Neogen. The industry participants are investing heavily in R&D to develop innovative products which would provide competitive advantage.

Some of the major players in sequencing and analysis instruments market include Life Technologies, Illumina, Thermo Fisher Scientific, and Roche. Few of the advanced sequencing technologies are Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: proton/ PGM sequencing and SOLiD (sequencing by Oligonucleotide Ligation and Detection) sequencing.

Digital genome market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2012 to 2024, for the following segments:

Digital Genome Market By Product
• Sequencing & Analyzer Instruments
• DNA/RNA Analysis Kits
• Sequencing Chips
• Sequencing & Analysis Software
• Sample Prep Instruments

Digital Genome Market By Application
• Microbiology
o Biological
o Clinical
o Industrial
• Reproductive & Genetic
• Transplantation
• Livestock and Agriculture
• Forensics
• Research and Development

Digital Genome Market By End-Use
• Diagnostics & Forensic Labs
• Academic Research Institutes
• Hospitals
• Bio-pharmaceutical companies

The above information is provided on a regional and country basis for the following:

• North America
o U.S.
o Canada

• Europe
o Germany
o UK
o Italy
o France
o Spain
o Russia

• Latin America (LATAM)
o Argentina
o Brazil
o Mexico

• Asia Pacific
o China
o Japan
o India
o Australia
• Middle East
o South Africa
o Saudi Arabia

Chapter 8. Company Profiles

8.1. Thermo Fisher

8.1.1. Business Overview

8.1.2. Financial Data

8.1.3. Industry Landscape

8.1.4. Strategic Outlook

8.2. Perkin Elmer

8.2.1. Business Overview

8.2.2. Financial Data

8.2.3. Industry Landscape

8.2.4. Strategic Outlook

8.3. Qiagen

8.3.1. Business Overview

8.3.2. Financial Data

8.3.3. Industry Landscape

8.3.4. Strategic Outlook

8.4. Illumina

8.4.1. Business Overview

8.4.2. Financial Data

8.4.3. Industry Landscape

8.4.4. Strategic Outlook

8.5. Becton Dickinson

8.5.1. Business Overview

8.5.2. Financial Data

8.5.3. Industry Landscape

8.5.4. Strategic Outlook

8.6. Agilent

8.6.1. Business Overview

8.6.2. Financial Data

8.6.3. Industry Landscape

8.6.4. Strategic Outlook

8.7. Sigma Aldrich

8.7.1. Business Overview

8.7.2. Financial Data

8.7.3. Industry Landscape

8.7.4. Strategic Outlook

8.8. Fluidigm

8.8.1. Business Overview

8.8.2. Financial Data

8.8.3. Industry Landscape

8.8.4. Strategic Outlook

8.9. Pacific Biosciences

8.9.1. Business Overview

8.9.2. Financial Data

8.9.3. Industry Landscape

8.9.4. Strategic Outlook

8.10. F. Hoffmann-La Roche

8.10.1. Business Overview

8.10.2. Financial Data

8.10.3. Industry Landscape

8.10.4. Strategic Outlook

8.11. Agios

8.11.1. Business Overview

8.11.2. Financial Data

8.11.3. Industry Landscape

8.11.4. Strategic Outlook

8.12. AVEO Oncology

8.12.1. Business Overview

8.12.2. Financial Data

8.12.3. Industry Landscape

8.12.4. Strategic Outlook

8.13. Biomarin

8.13.1. Business Overview

8.13.2. Financial Data

8.13.3. Industry Landscape

8.13.4. Strategic Outlook

8.14. BioReference

8.14.1. Business Overview

8.14.2. Financial Data

8.14.3. Industry Landscape

8.14.4. Strategic Outlook

8.15. Cancer Genetics

8.15.1. Business Overview

8.15.2. Financial Data

8.15.3. Industry Landscape

8.15.4. Strategic Outlook

8.16. Clovis Oncology

8.16.1. Business Overview

8.16.2. Financial Data

8.16.3. Industry Landscape

8.16.4. Strategic Outlook

8.17. CombiMatrix

8.17.1. Business Overview

8.17.2. Financial Data

8.17.3. Industry Landscape

8.17.4. Strategic Outlook

8.18. Foundation Medicine

8.18.1. Business Overview

8.18.2. Financial Data

8.18.3. Industry Landscape

8.18.4. Strategic Outlook

8.19. Genomic Health

8.19.1. Business Overview

8.19.2. Financial Data

8.19.3. Industry Landscape

8.19.4. Strategic Outlook

8.20. MacroGen (Korea)

8.20.1. Business Overview

8.20.2. Financial Data

8.20.3. Industry Landscape

8.20.4. Strategic Outlook

8.21. LabCorp

8.21.1. Business Overview

8.21.2. Financial Data

8.21.3. Industry Landscape

8.21.4. Strategic Outlook

8.22. NanoString Technologies

8.22.1. Business Overview

8.22.2. Financial Data

8.22.3. Industry Landscape

8.22.4. Strategic Outlook

8.23. Quest

8.23.1. Business Overview

8.23.2. Financial Data

8.23.3. Industry Landscape

8.23.4. Strategic Outlook

8.24. Regeneron

8.24.1. Business Overview

8.24.2. Financial Data

8.24.3. Industry Landscape

8.24.4. Strategic Outlook

8.25. Rosetta Genomics

8.25.1. Business Overview

8.25.2. Financial Data

8.25.3. Industry Landscape

8.25.4. Strategic Outlook

8.26. Sequenom

8.26.1. Business Overview

8.26.2. Financial Data

8.26.3. Industry Landscape

8.26.4. Strategic Outlook

8.27. Tesaro

8.27.1. Business Overview

8.27.2. Financial Data

8.27.3. Industry Landscape

8.27.4. Strategic Outlook

8.28. Veracyte

8.28.1. Business Overview

8.28.2. Financial Data

8.28.3. Industry Landscape

8.28.4. Strategic Outlook

8.29. Trovagene

8.29.1. Business Overview

8.29.2. Financial Data

8.29.3. Industry Landscape

8.29.4. Strategic Outlook

8.30. BGI (China)

8.30.1. Business Overview

8.30.2. Financial Data

8.30.3. Industry Landscape

8.30.4. Strategic Outlook

8.31. Affymetrix

8.31.1. Business Overview

8.31.2. Financial Data

8.31.3. Industry Landscape

8.31.4. Strategic Outlook

8.32. Neogen

8.32.1. Business Overview

8.32.2. Financial Data

8.32.3. Industry Landscape

8.32.4. Strategic Outlook

8.33. Zoetis

8.33.1. Business Overview

8.33.2. Financial Data

8.33.3. Industry Landscape

8.33.4. Strategic Outlook

8.34. bioMerieux

8.34.1. Business Overview

8.34.2. Financial Data

8.34.3. Industry Landscape

8.34.4. Strategic Outlook

8.35. Cepheid

8.35.1. Business Overview

8.35.2. Financial Data

8.35.3. Industry Landscape

8.35.4. Strategic Outlook

8.36. GenMark Diagnostics

8.36.1. Business Overview

8.36.2. Financial Data

8.36.3. Industry Landscape

8.36.4. Strategic Outlook

8.37. Nanosphere

8.37.1. Business Overview

8.37.2. Financial Data

8.37.3. Industry Landscape

8.37.4. Strategic Outlook

8.38. General Electric

8.38.1. Business Overview

8.38.2. Financial Data

8.38.3. Industry Landscape

8.38.4. Strategic Outlook

8.39. Quintiles

8.39.1. Business Overview

8.39.2. Financial Data

8.39.3. Industry Landscape

8.39.4. Strategic Outlook

8.40. 23andMe

8.40.1. Business Overview

8.40.2. Financial Data

8.40.3. Industry Landscape

8.40.4. Strategic Outlook

8.41. Counsyl

8.41.1. Business Overview

8.41.2. Financial Data

8.41.3. Industry Landscape

8.41.4. Strategic Outlook

8.42. Ancestry

8.42.1. Business Overview

8.42.2. Financial Data

8.42.3. Industry Landscape

8.42.4. Strategic Outlook

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Genome Market | Pinnacle Companies :- Life Technologies, Illumina, Thermo Fisher Scientific, Roche, Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: proton/ PGM sequencing and SOLiD (sequencing by Oligonucleotide Ligation and Detec here

News-ID: 1211233 • Views:

More Releases from Global Market Insights, Inc.

Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health. This in turn has led to a surge in demand for various functional foods
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock. According to Global Market Insights Inc estimates
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key players Eaton, Schneider, Siemens, Hitachi, Powell, Hubbell
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091 Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group
Prenatal Vitamin Ingredients Market New Entrants, Risk Factors, Market Expansion …
The rise in the instances of miscarriages on account of poor diet and hygiene will anchor the consumption of prenatal vitamin ingredients. Excessive intake of junk food has resulted in the scarcity of important nutrients in pregnant women that could adversely affect the fetus health and development. Furthermore, prenatal vitamin ingredients possess additional nutritional components that are not so easily sourced from regular food items and products. Prenatal vitamin ingredients can

All 5 Releases


More Releases for Business

Business Consulting Company, Business Consulting Firm, Business Consulting Servi …
The market research is an essential portion of any business strategy and primarily comprises of the data collecting about the markets and consumers in those markets. In recent’s globalized business surroundings, effective market research is a critical portion of any business’s efforts to compete successfully. At Ken Research, the market research services support businesses identify growth opportunities and form a competitive strategy reliant on the deep understanding of consumers and
Business to Business Media Market 2019 Business Scenario – Bloomberg, IBM, Ora …
A new Profession Intelligence Report released by Stats and Reports with the title Global Business to Business Media Market "can grow into the most important market in the world that has played an important role in making progressive impacts on the global economy. Global Business to Business Media Market Report presents a dynamic vision to conclude and research market size, market hope and competitive environment. The study is derived from
Business to Business (B2B) Telecommunication Market Prolific Business Methodolog …
B2B telecommunications is a form of communications that takes place between companies in different forms such as text, voice, video, emails, and among others. B2B telecommunication providers maintain systems that transmit data, text, sound, and voice and video, which facilitates direct communication between businesses. Telecommunications platforms can also be utilized by marketers in order to boost a company's visibility within the industry and identify networking opportunities. Request For Customization of Research
Business Alliance Market Growing Dynamically with Leading Top Key Players like B …
A business alliance is an agreement between businesses, usually motivated by cost reduction and improved service for the customer. Alliances are often bounded by a single agreement with equitable risk and opportunity share for all parties involved and are typically managed by an integrated project team. An example of this is code sharing in airline alliances. The Global Business Alliance Market 2019 research provides a basic overview of the industry including
Global Interferon Market Business Growth, Business Opportunities, Business Outlo …
Albany, NY, USA / 16 Oct 2018: - A New fresh research report presented by KD Market Insights provides a detailed analysis of “Global Interferon Market Size, Trends, Opportunity and Forecast to 2023” research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges the business
Global Intramuscular Immune Globulin Market Business Growth, Business Opportunit …
Albany, NY, USA / 16 Oct 2018: - A New fresh research report presented by KD Market Insights provides a detailed analysis of “Global Intramuscular Immune Globulin Market Size, Trends, Opportunity and Forecast to 2023” research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges